Article
FDA greenlights Amylyx's ALS drug
Rating:
0.0
Views:
34
Likes:
1
Library:
1
Amylyx Pharmaceuticals Inc said on Thursday the U.S. Food and Drug Administration approved its drug for slowing progression of ALS, or amyotrophic lateral sclerosis, and potentially delaying death, sending shares of the company up nearly 14% in extended trading.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value